These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 26465080)
1. Quinone reductase 2 as a promising target of melatonin therapeutic actions. Boutin JA Expert Opin Ther Targets; 2016; 20(3):303-17. PubMed ID: 26465080 [TBL] [Abstract][Full Text] [Related]
2. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489 [TBL] [Abstract][Full Text] [Related]
3. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Calamini B; Santarsiero BD; Boutin JA; Mesecar AD Biochem J; 2008 Jul; 413(1):81-91. PubMed ID: 18254726 [TBL] [Abstract][Full Text] [Related]
4. Old and new inhibitors of quinone reductase 2. Ferry G; Hecht S; Berger S; Moulharat N; Coge F; Guillaumet G; Leclerc V; Yous S; Delagrange P; Boutin JA Chem Biol Interact; 2010 Jul; 186(2):103-9. PubMed ID: 20399199 [TBL] [Abstract][Full Text] [Related]
5. Quinone reductase 2 and antidepressant effect of melatonin derivatives. Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117 [TBL] [Abstract][Full Text] [Related]
6. In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones. Cassagnes LE; Perio P; Ferry G; Moulharat N; Antoine M; Gayon R; Boutin JA; Nepveu F; Reybier K Free Radic Biol Med; 2015 Dec; 89():126-34. PubMed ID: 26386287 [TBL] [Abstract][Full Text] [Related]
7. Actions of melatonin in the reduction of oxidative stress. A review. Reiter RJ; Tan DX; Osuna C; Gitto E J Biomed Sci; 2000; 7(6):444-58. PubMed ID: 11060493 [TBL] [Abstract][Full Text] [Related]
8. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. Manchester LC; Coto-Montes A; Boga JA; Andersen LP; Zhou Z; Galano A; Vriend J; Tan DX; Reiter RJ J Pineal Res; 2015 Nov; 59(4):403-19. PubMed ID: 26272235 [TBL] [Abstract][Full Text] [Related]
9. [Melatonin as an antioxidant]. Skrzydlewska E Postepy Hig Med Dosw; 2001; 55(6):871-89. PubMed ID: 11875783 [TBL] [Abstract][Full Text] [Related]
11. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Boutin JA; Saunier C; Guenin SP; Berger S; Moulharat N; Gohier A; Delagrange P; Cogé F; Ferry G Arch Biochem Biophys; 2008 Sep; 477(1):12-9. PubMed ID: 18502195 [TBL] [Abstract][Full Text] [Related]
12. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Skaper SD; Floreani M; Ceccon M; Facci L; Giusti P Ann N Y Acad Sci; 1999; 890():107-18. PubMed ID: 10668417 [TBL] [Abstract][Full Text] [Related]
13. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. Zhang HM; Zhang Y J Pineal Res; 2014 Sep; 57(2):131-46. PubMed ID: 25060102 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234 [TBL] [Abstract][Full Text] [Related]
15. Melatonin and Oxidative Stress in the Diabetic State: Clinical Implications and Potential Therapeutic Applications. Espino J; Rodríguez AB; Pariente JA Curr Med Chem; 2019; 26(22):4178-4190. PubMed ID: 29637854 [TBL] [Abstract][Full Text] [Related]
16. Insights into the redox cycle of human quinone reductase 2. Reybier K; Perio P; Ferry G; Bouajila J; Delagrange P; Boutin JA; Nepveu F Free Radic Res; 2011 Oct; 45(10):1184-95. PubMed ID: 21762045 [TBL] [Abstract][Full Text] [Related]
17. Melatonin: action as antioxidant and potential applications in human disease and aging. Bonnefont-Rousselot D; Collin F Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677 [TBL] [Abstract][Full Text] [Related]